Upexi, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1284069,
    "name": "Upexi, Inc.",
    "stock_name": "Upexi, Inc.",
    "full_name": "Upexi, Inc.",
    "name_url": "stocks-analysis/upexi-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.85",
    "chg": -0.04,
    "chgp": "-1.55%",
    "dir": -1,
    "prev_price": "2.90",
    "mcapval": "333.31",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2310,
    "indexname": "S&P 500",
    "isin": "US39959A1060",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.37 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/upexi-inc-1284069-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Upexi, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-upexi-inc-technically-bullish-or-bearish-3547064",
        "imagepath": "",
        "date": "2025-09-20 19:46:15",
        "description": "As of 12 September 2025, the technical trend for Upexi, Inc. has changed from sideways to mildly bullish. The current stance is mildly bullish, driven by a bullish daily moving average and a monthly MACD that is mildly bullish, despite the weekly MACD and KST being mildly bearish. The Bollinger Bands also reflect a mildly bullish trend on a monthly basis. \n\nIn terms of performance, Upexi has significantly outperformed the S&P 500 year-to-date with a return of 94.3% compared to the S&P's 12.22%. However, over the past year, Upexi's return of 62.38% still shows strong performance relative to the S&P 500's 17.14%...."
      },
      {
        "title": "Is Upexi, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-upexi-inc-overvalued-or-undervalued-3543503",
        "imagepath": "",
        "date": "2025-09-20 18:21:10",
        "description": "As of 28 September 2022, the valuation grade for Upexi, Inc. moved from attractive to risky, indicating a shift in perception regarding its financial health. Based on the available metrics, Upexi appears to be overvalued, particularly given its extreme P/B ratio of 229.66 and negative EV to EBITDA of -44.95, which suggest significant challenges in generating earnings relative to its valuation. Additionally, the company's ROE stands at a concerning -616.52%, further highlighting its struggles.\n\nIn comparison to its peers, Upexi's valuation ratios are notably unfavorable; for instance, Chromadex Corp. has a P/E of 39.82, while LifeVantage Corp. shows a more reasonable P/E of 14.81. This stark contrast underscores Upexi's risky standing in the market. Despite a strong year-to-date return of 94.3% compared to the S&P 500's 12.22%, the long-term performance reveals a troubling trend, with a 3-year return of -91...."
      }
    ],
    "total": 6,
    "sid": "1284069",
    "stock_news_url": "https://www.marketsmojo.com/news/upexi-inc-1284069"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Upexi, Inc. technically bullish or bearish?

2025-09-20 19:46:15

As of 12 September 2025, the technical trend for Upexi, Inc. has changed from sideways to mildly bullish. The current stance is mildly bullish, driven by a bullish daily moving average and a monthly MACD that is mildly bullish, despite the weekly MACD and KST being mildly bearish. The Bollinger Bands also reflect a mildly bullish trend on a monthly basis. In terms of performance, Upexi has significantly outperformed the S&P 500 year-to-date with a return of 94.3% compared to the S&P's 12.22%. However, over the past year, Upexi's return of 62.38% still shows strong performance relative to the S&P 500's 17.14%....

Is Upexi, Inc. overvalued or undervalued?

2025-09-20 18:21:10

As of 28 September 2022, the valuation grade for Upexi, Inc. moved from attractive to risky, indicating a shift in perception regarding its financial health. Based on the available metrics, Upexi appears to be overvalued, particularly given its extreme P/B ratio of 229.66 and negative EV to EBITDA of -44.95, which suggest significant challenges in generating earnings relative to its valuation. Additionally, the company's ROE stands at a concerning -616.52%, further highlighting its struggles. In comparison to its peers, Upexi's valuation ratios are notably unfavorable; for instance, Chromadex Corp. has a P/E of 39.82, while LifeVantage Corp. shows a more reasonable P/E of 14.81. This stark contrast underscores Upexi's risky standing in the market. Despite a strong year-to-date return of 94.3% compared to the S&P 500's 12.22%, the long-term performance reveals a troubling trend, with a 3-year return of -91....

View All News